709 related articles for article (PubMed ID: 9429077)
21. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo.
Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170
[TBL] [Abstract][Full Text] [Related]
22. Tissue distribution of mRNA for heparin-binding epidermal growth factor.
Vaughan TJ; Pascall JC; Brown KD
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):681-4. PubMed ID: 1445231
[TBL] [Abstract][Full Text] [Related]
23. Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors Mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy.
Varani J; Zeigler M; Dame MK; Kang S; Fisher GJ; Voorhees JJ; Stoll SW; Elder JT
J Invest Dermatol; 2001 Dec; 117(6):1335-41. PubMed ID: 11886492
[TBL] [Abstract][Full Text] [Related]
24. KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin.
Richardson GD; Bazzi H; Fantauzzo KA; Waters JM; Crawford H; Hynd P; Christiano AM; Jahoda CA
Development; 2009 Jul; 136(13):2153-64. PubMed ID: 19474150
[TBL] [Abstract][Full Text] [Related]
25. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.
Sakai M; Zhang M; Homma T; Garrick B; Abraham JA; McKanna JA; Harris RC
J Clin Invest; 1997 May; 99(9):2128-38. PubMed ID: 9151785
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.
Naef M; Yokoyama M; Friess H; Büchler MW; Korc M
Int J Cancer; 1996 May; 66(3):315-21. PubMed ID: 8621250
[TBL] [Abstract][Full Text] [Related]
27. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.
Mitamura T; Higashiyama S; Taniguchi N; Klagsbrun M; Mekada E
J Biol Chem; 1995 Jan; 270(3):1015-9. PubMed ID: 7836353
[TBL] [Abstract][Full Text] [Related]
28. Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.
Zhou Z; Harding PA
Cell Prolif; 2007 Apr; 40(2):213-30. PubMed ID: 17472728
[TBL] [Abstract][Full Text] [Related]
29. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M
EMBO J; 2001 Jul; 20(13):3342-50. PubMed ID: 11432822
[TBL] [Abstract][Full Text] [Related]
30. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.
Stoll S; Garner W; Elder J
J Clin Invest; 1997 Sep; 100(5):1271-81. PubMed ID: 9276746
[TBL] [Abstract][Full Text] [Related]
31. [A short form of the heparin-binding EGF-like growth factor with a changed EGF domain].
Luk'ianov EV; Viedlokha A; Kuianskaia DV; Olsnes S; Kozlov IuV
Mol Biol (Mosk); 2002; 36(1):76-83. PubMed ID: 11862716
[TBL] [Abstract][Full Text] [Related]
32. Latent transforming growth factor beta-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor.
Brooke JS; Cha JH; Eidels L
BMC Cell Biol; 2002; 3():2. PubMed ID: 11846885
[TBL] [Abstract][Full Text] [Related]
33. Heparin-binding epidermal growth factor-like growth factor and transforming growth factor-alpha in human non-small cell lung cancers.
Chong IW; Lin SR; Lin MS; Huang MS; Tsai MS; Hwang JJ
J Formos Med Assoc; 1997 Aug; 96(8):579-85. PubMed ID: 9290266
[TBL] [Abstract][Full Text] [Related]
34. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.
Shirakata Y; Kimura R; Nanba D; Iwamoto R; Tokumaru S; Morimoto C; Yokota K; Nakamura M; Sayama K; Mekada E; Higashiyama S; Hashimoto K
J Cell Sci; 2005 Jun; 118(Pt 11):2363-70. PubMed ID: 15923649
[TBL] [Abstract][Full Text] [Related]
35. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein.
Higashiyama S; Lau K; Besner GE; Abraham JA; Klagsbrun M
J Biol Chem; 1992 Mar; 267(9):6205-12. PubMed ID: 1556128
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site.
Suzuki M; Raab G; Moses MA; Fernandez CA; Klagsbrun M
J Biol Chem; 1997 Dec; 272(50):31730-7. PubMed ID: 9395517
[TBL] [Abstract][Full Text] [Related]
37. Expression of heparin-binding epidermal growth factor-like growth factor in rat brain.
Hayase Y; Higashiyama S; Sasahara M; Amano S; Nakagawa T; Taniguchi N; Hazama F
Brain Res; 1998 Feb; 784(1-2):163-78. PubMed ID: 9518593
[TBL] [Abstract][Full Text] [Related]
38. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus.
Davis KM; Brigstock DR; Johnson PR; Crissman-Combs MA; McCarthy DW; Downing MT; Besner GE
Protein Expr Purif; 1996 Aug; 8(1):57-67. PubMed ID: 8812835
[TBL] [Abstract][Full Text] [Related]
39. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells.
Takemura T; Kondo S; Homma T; Sakai M; Harris RC
J Biol Chem; 1997 Dec; 272(49):31036-42. PubMed ID: 9388253
[TBL] [Abstract][Full Text] [Related]
40. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor.
Raab G; Kover K; Paria BC; Dey SK; Ezzell RM; Klagsbrun M
Development; 1996 Feb; 122(2):637-45. PubMed ID: 8625815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
